Compass: A Phase 3 Trial of Efficacy, Safety, and Tolerability of COMP360 (Psilocybin) in Participants with Treatment Resistant Depression

Trial Status:

Sponsor:

COMPASS Pathways

ClinicalTrials.gov:

NCT05624268